Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients

International Immunology

Volumn 16, Issue 11, 2004, Pages 1595-1604

  Köller, Marcus ^a   Zwölfer, Bettina ^a   Steiner, Günter ^a   Smolen, Josef S ^a   Scheinecker, Clemens ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dendritic cells; Monocytes; SLE; Toll like receptors

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CYCLOPHOSPHAMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL ACTIVITY; CELL MATURATION; CELL POPULATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGY; IN VITRO STUDY; MALE; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; UPREGULATION;

ADULT; ANTIGEN PRESENTATION; AUTOANTIGENS; B-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTES;

EID: 8344271070     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh160     Document Type: Article

References (37)

1. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
2. Inaba, K., Metlay, J. P., Crowley, M. T. and Steinman, R. M. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631.
3. Guery, J. C. and Adorini, L. 1995. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J. Immunol. 154:536.
4. Steinman, R. M. and Nussenzweig, M. C. 2002. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. USA 99:351.
5. Cederblad, B., Blomberg, S., Vallin, H., Perers, A., Alm, G. V. and Ronnblom, L. 1998. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J. Autoimmun. 11:465.
6. Vallin, H., Blomberg, S., Alm, G. V., Cederblad, B. and Ronnblom, L. 1999. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin. Exp. Immunol. 115:196.
7. Scheinecker, C., Zwolfer, B., Koller, M., Manner, G. and Smolen, J. S. 2001. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies. Arthritis Rheum. 44:856.
8. Blanco, P., Palucka, A. K., Gill, M., Pascual, V. and Banchereau, J. 2001. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294:1540.
9. Kuntz, M. M., Innes, J. B. and Weksler, M. E. 1979. The cellular basis of the impaired autologous mixed lymphocyte reaction in patients with systemic lupus erythematosus. J. Clin. Investig. 63:151.
10. Gottlieb, A. B., Lahita, R. G., Chiorazzi, N. and Kunkel, H. G. 1979. Immune function in systemic lupus erythematosus. Impairment of in vitro T-cell proliferation and in vivo antibody response to exogenous antigen. J. Clin. Investig. 63:885.
11. Sakane, T., Steinberg, A. D. and Green, I. 1978. Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 75:3464.
12. Smolen, J. S., Siminovitch, K., Luger, T. A. and Steinberg, A. D. 1983. Responder cells in the human autologous mixed lymphocyte reaction (AMLR). Characterization and interactions in healthy individuals and patients with systemic lupus erythematosus. Behring. Inst. Mitt. 72:153.
13. Bouza, E., Moya, J. G. and Munoz, P. 2001. Infections in systemic lupus erythematosus and rheumatoid arthritis. Infect. Dis. Clin. N. Am. 15:335.
14. Juarez, M., Misischia, R. and Alarcon, G. S. 2003. Infections in systemic connective tissue diseases: systemic lupus erythematosus, scleroderma, and polymyositis/dermatomyositis. Rheum. Dis. Clin. N. Am. 29:163.
15. Tan, E. M., Cohen, A. S., Fries, J. F. et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271.
16. Bencivelli, W., Vitali, C., Isenberg, D. A. et al. 1992. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerised clinical chart and its application to the comparison of different indices of disease activity. The European Consensus Study Group for Disease Activity in SLE. Clin. Exp. Rheumatol. 10:549.
17. Miltenyi, S., Müller, W., Weichel, W. and Radbruch, A. 1990. High gradient magnetic cell separation with MACS. Cytometry 11:231.
18. Sallusto, F. and Lanzavecchia, A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109.
19. Romani, N., Gruner, S., Brang, D. et al. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83.
20. Pickl, W. F., Majdic, O., Kohl, P. et al. 1996. Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes. J. Immunol. 157:3850.
21. Bender, A., Sapp, M., Schuler, G., Steinman, R. M. and Bhardwaj, N. 1996. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196:121.
22. Richardson, B. C., Yung, R. L., Johnson, K. J., Rowse, P. E. and Lalwani, N. D. 1996. Monocyte apoptosis in patients with active lupus. Arthritis Rheum. 39:1432.
23. Shoshan, Y., Shapira, I., Toubi, E., Frolkis, I., Yaron, M. and Mevorach, D. 2001. Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells. J. Immunol. 167:5963.
24. Nagai, H., Sztein, M. B., Steeg, P. S., Hooks, J. J., Oppenheim, J. J. and Steinberg, A. D. 1984. Diminished peripheral blood monocyte DR antigen expression in systemic lupus erythematosus. Clin. Exp. Rheumatol. 2:131.
25. Steinbach, F., Henke, F., Krause, B., Thiele, B., Burmester, G. R. and Hiepe, F. 2000. Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann. Rheum. Dis. 59:283.
26. Medzhitov, R. and Janeway, C., Jr. 2000. The Toll receptor family and microbial recognition. Trends Microbiol. 8:452.
27. Beutler, B. 2002. Toll-like receptors: how they work and what they do. Curr. Opin. Hematol. 9:2.
28. Scheinecker, C., McHugh, R., Shevach, E. M. and Germain, R. N. 2002. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196:1079.
29. de Vos, A. F., van Meurs, M., Brok, H. P. et al. 2002. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J. Immunol. 169:5415.
30. Glimcher, L. H., Longo, D. L., Green, I. and Schwartz, R. H. 1981. Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. J. Exp. Med. 154:1652.
31. Moody, C. E., Gupta, S. and Weksler, M. E. 1983. Lymphocyte transformation induced by autologous cells. XV. Xenoantigens are not required for the proliferative response observed in the autologous mixed lymphocyte reaction. J. Clin. Investig. 3:100.
32. Banchereau, J., Briere, F., Caux, C. et al. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
33. Repique, C. J., Li, A., Brickey, W. J., Ting, J. P., Collins, F. M. and Morris, S. L. 2003. Susceptibility of mice deficient in the MHC class II transactivator to infection with Mycobacterium tuberculosis. Scand. J. Immunol. 58:15.
34. Guardiola, J. and Maffei, A. 1993. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases. Crit. Rev. Immunol. 13:247.
35. Liossis, S. N., Vassilopoulos, D., Kovacs, B. and Tsokos, G. C. 1997. Immune cell biochemical abnormalities in systemic lupus erythematosus. Clin. Exp. Rheumatol. 15:677.
36. Klint, C., Truedsson, L., Andreasson, A., Johansson, I. and Sturfelt, G. 2000. Toxic effects of SLE serum on normal monocytes in vitro: cell death induced by apoptosis related to complement dysfunction. Lupus 9:278.
37. Tsokos, G. C., Kovacs, B., Sfilkakis, P. P., Theocharis, S., Vogelsang, S. and Via, C. S. 1996. Defective antigen-presenting cell function in patients with systemic lupus erythematosus. Arthritis Rheum. 39:600.